ksi-101
Recombinant proteinexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Jul 16, 2025 (NCT06996080)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 3 Sponsor(trial)
Mechanism of action
- Vascular endothelial growth factor AINHIBITOR
VEGFA inhibitor
- Interleukin-6INHIBITOR
IL6 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06990399 | Phase 3 | Jul 30, 2025 | Kodiak Sciences Inc |
| NCT06996080 | Phase 3 | Jul 16, 2025 | Kodiak Sciences Inc |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kodiak Sciences Inc | For profit | 2 | 2 | 1 | 2025 |
1 organizations
Page 1 / 1